MicroRNA in autoimmunity and autoimmune diseases

Journal of Autoimmunity

Volumn 32, Issue 3-4, 2009, Pages 189-194

  Pauley, Kaleb M ^a   Cha, Seunghee ^a   Chan, Edward K L ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Autoimmunity; Immune response; MicroRNA; Rheumatiod arthritis; Systemic lupus erythematosus

Indexed keywords

IMMUNOGLOBULIN; MESSENGER RNA; MICRORNA; TOLL LIKE RECEPTOR;

3' UNTRANSLATED REGION; ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; AUTOIMMUNITY; BIOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; GENE CONTROL; GENE EXPRESSION; GERMINAL CENTER; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RHEUMATOID ARTHRITIS; RNA TRANSLATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; GENE SILENCING; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, INNATE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS; TOLL-LIKE RECEPTORS;

EID: 67349273027     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.02.012     Document Type: Article

References (67)

1. Lee R.C., Feinbaum R.L., and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 (1993) 843-854
2. Wightman B., Ha I., and Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75 (1993) 855-862
3. Filipowicz W., Bhattacharyya S.N., and Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 9 (2008) 102-114
4. Griffiths-Jones S. The microRNA Registry. Nucleic Acids Res 32 (2004) D109-D111
5. Griffiths-Jones S. miRBase: the microRNA sequence database. Methods Mol Biol 342 (2006) 129-138
6. Lewis B.P., Burge C.B., and Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005) 15-20
7. Cai X., Hagedorn C.H., and Cullen B.R. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 10 (2004) 1957-1966
8. Lee Y., Kim M., Han J., Yeom K.H., Lee S., Baek S.H., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23 (2004) 4051-4060
9. Denli A.M., Tops B.B., Plasterk R.H., Ketting R.F., and Hannon G.J. Processing of primary microRNAs by the microprocessor complex. Nature 432 (2004) 231-235
10. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., et al. The microprocessor complex mediates the genesis of microRNAs. Nature 432 (2004) 235-240
11. Han J., Lee Y., Yeom K.H., Kim Y.K., Jin H., and Kim V.N. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 18 (2004) 3016-3027
12. Landthaler M., Yalcin A., and Tuschl T. The human DiGeorge syndrome critical region gene 8 and Its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 14 (2004) 2162-2167
13. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425 (2003) 415-419
14. Lund E., Guttinger S., Calado A., Dahlberg J.E., and Kutay U. Nuclear export of microRNA precursors. Science 303 (2004) 95-98
15. Yi R., Qin Y., Macara I.G., and Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17 (2003) 3011-3016
16. Zeng Y., and Cullen B.R. Structural requirements for pre-microRNA binding and nuclear export by Exportin 5. Nucleic Acids Res 32 (2004) 4776-4785
17. Du T., and Zamore P.D. microPrimer: the biogenesis and function of microRNA. Development 132 (2005) 4645-4652
18. Eulalio A., Huntzinger E., and Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell 132 (2008) 9-14
19. Berezikov E., Chung W.J., Willis J., Cuppen E., and Lai E.C. Mammalian mirtron genes. Mol Cell 28 (2007) 328-336
20. Okamura K., Hagen J.W., Duan H., Tyler D.M., and Lai E.C. The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell 130 (2007) 89-100
21. Ruby J.G., Jan C.H., and Bartel D.P. Intronic microRNA precursors that bypass Drosha processing. Nature 448 (2007) 83-86
22. Liu J., Carmell M.A., Rivas F.V., Marsden C.G., Thomson J.M., Song J.J., et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science 305 (2004) 1437-1441
23. Meister G., Landthaler M., Patkaniowska A., Dorsett Y., Teng G., and Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 15 (2004) 185-197
24. Eystathioy T., Chan E.K.L., Tenenbaum S.A., Keene J.D., Griffith K., and Fritzler M.J. A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol Biol Cell 13 (2002) 1338-1351
25. Bhanji R.A., Eystathioy T., Chan E.K.L., Bloch D.B., and Fritzler M.J. Clinical and serological features of patients with autoantibodies to GW/P bodies. Clin Immunol 125 (2007) 247-256
26. Ingelfinger D., Arndt-Jovin D.J., Luhrmann R., and Achsel T. The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci. RNA 8 (2002) 1489-1501
27. Sheth U., and Parker R. Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300 (2003) 805-808
28. van Dijk E., Cougot N., Meyer S., Babajko S., Wahle E., and Seraphin B. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J 21 (2002) 6915-6924
29. Satoh M., Langdon J.J., Chou C.H., McCauliffe D.P., Treadwell E.L., Ogasawara T., et al. Characterization of the Su antigen, a macromolecular complex of 100/102 and 200-kDa proteins recognized by autoantibodies in systemic rheumatic diseases. Clin Immunol Immunopathol 73 (1994) 132-141
30. Jakymiw A., Ikeda K., Fritzler M.J., Reeves W.H., Satoh M., and Chan E.K.L. Autoimmune targeting of key components of RNA interference. Arthritis Res Ther 8 (2006) R87
31. Taganov K.D., Boldin M.P., Chang K.J., and Baltimore D. NF-B-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103 (2006) 12481-12486
32. Perry M.M., Moschos S.A., Williams A.E., Shepherd N.J., Larner-Svensson H.M., and Lindsay M.A. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol 180 (2008) 5689-5698
33. O'Connell R.M., Taganov K.D., Boldin M.P., Cheng G., and Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104 (2007) 1604-1609
34. Tili E., Michaille J.J., Cimino A., Costinean S., Dumitru C.D., Adair B., et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179 (2007) 5082-5089
35. Tam W. Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 274 (2001) 157-167
36. Tam W., Ben-Yehuda D., and Hayward W.S. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol Cell Biol 17 (1997) 1490-1502
37. Haasch D., Chen Y.W., Reilly R.M., Chiou X.G., Koterski S., Smith M.L., et al. T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell Immunol 217 (2002) 78-86
38. van den Berg A., Kroesen B.J., Kooistra K., de Jong D., Briggs J., Blokzijl T., et al. High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 37 (2003) 20-28
39. Costinean S., Zanesi N., Pekarsky Y., Tili E., Volinia S., Heerema N., et al. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A 103 (2006) 7024-7029
40. Kluiver J., Poppema S., de Jong D., Blokzijl T., Harms G., Jacobs S., et al. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207 (2005) 243-249
41. Metzler M., Wilda M., Busch K., Viehmann S., and Borkhardt A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39 (2004) 167-169
42. Rodriguez A., Vigorito E., Clare S., Warren M.V., Couttet P., Soond D.R., et al. Requirement of bic/microRNA-155 for normal immune function. Science 316 (2007) 608-611
43. Thai T.H., Calado D.P., Casola S., Ansel K.M., Xiao C., Xue Y., et al. Regulation of the germinal center response by microRNA-155. Science 316 (2007) 604-608
44. Vigorito E., Perks K.L., breu-Goodger C., Bunting S., Xiang Z., Kohlhaas S., et al. MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27 (2007) 847-859
45. Neilson J.R., Zheng G.X., Burge C.B., and Sharp P.A. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev 21 (2007) 578-589
46. Wu H., Neilson J.R., Kumar P., Manocha M., Shankar P., Sharp P.A., et al. miRNA profiling of naive, effector and memory CD8 T cells. PLoS ONE 2 (2007) e1020
47. Zhou B., Wang S., Mayr C., Bartel D.P., and Lodish H.F. miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A 104 (2007) 7080-7085
48. Chen C.Z., Li L., Lodish H.F., and Bartel D.P. MicroRNAs modulate hematopoietic lineage differentiation. Science 303 (2004) 83-86
49. Li Q.J., Chau J., Ebert P.J., Sylvester G., Min H., Liu G., et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129 (2007) 147-161
50. de Yebenes V.G., Belver L., Pisano D.G., Gonzalez S., Villasante A., Croce C., et al. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J Exp Med 205 (2008) 2199-2206
51. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M.L., Nervi C., et al. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123 (2005) 819-831
52. Fukao T., Fukuda Y., Kiga K., Sharif J., Hino K., Enomoto Y., et al. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 129 (2007) 617-631
53. Xiao C., Calado D.P., Galler G., Thai T.H., Patterson H.C., Wang J., et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131 (2007) 146-159
54. Yu D., Tan A.H., Hu X., Athanasopoulos V., Simpson N., Silva D.G., et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 450 (2007) 299-303
55. Liston A., Lu L.F., O'Carroll D., Tarakhovsky A., and Rudensky A.Y. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 205 (2008) 1993-2004
56. Zhou X., Jeker L.T., Fife B.T., Zhu S., Anderson M.S., McManus M.T., et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 205 (2008) 1983-1991
57. Smolen J.S., Aletaha D., Koeller M., Weisman M.H., and Emery P. New therapies for treatment of rheumatoid arthritis. Lancet 370 (2007) 1861-1874
58. Bresnihan B., varo-Gracia J.M., Cobby M., Doherty M., Domljan Z., Emery P., et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 41 (1998) 2196-2204
59. Lipsky P.E., van der Heijde D.M., St Clair E.W., Furst D.E., Breedveld F.C., Kalden J.R., et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343 (2000) 1594-1602
60. Nakasa T., Miyaki S., Okubo A., Hashimoto M., Nishida K., Ochi M., et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 58 (2008) 1284-1292
61. Pauley K.M., Satoh M., Chan A.L., Bubb M.R., Reeves W.H., and Chan E.K.L. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10 (2008) R101
62. Stanczyk J., Pedrioli D.M., Brentano F., Sanchez-Pernaute O., Kolling C., Gay R.E., et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 58 (2008) 1001-1009
63. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
64. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
65. Dai Y., Huang Y.S., Tang M., Lv T.Y., Hu C.X., Tan Y.H., et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 16 (2007) 939-946
66. Dai Y., Sui W., Lan H., Yan Q., Huang H., and Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int (2008)
67. Bauer M., Kinkl N., Meixner A., Kremmer E., Riemenschneider M., Forstl H., et al. Prevention of interferon-stimulated gene expression using microRNA-designed hairpins. Gene Ther 16 (2008) 142-147